KNOWLEDGE THROUGH GENETICS

 

For medical doctors and health companies,
HeartGenetics is developing technologies for cardiovascular
genetic testing and clinical reporting.
It is dedicated to improve people’s health, one at a time.



HeartGenetics was founded in 2013 (IST spin-off) after 7 years of research between multidisciplinary teams including molecular and computational biologists, geneticists and cardiologists from referenced Portuguese Hospitals.

HeartGenetics has developed a disruptive methodology that includes (i) a DNA MICROCHIP array platform and (ii) efficient and scalable algorithms for data processing and clinical reporting.

This new methodology is relevant for improving cardiovascular diagnostics, genetic testing scaling up and providing cost-effective genetic tools to clinical practice.




PRODUCTS & SERVICES

HeartGenetics’ main products are:

A) Cardiovascular Genetic Testing (using DNA Microchip)
HeartGenetics’s strategy uses specific knowledge to develop cost-effective genetic tests to specific pathologies, which can improve clinical diagnosis and prognosis and be used by any clinician.
Key benefits
/ test ALL known mutations (as good as sequencing methods)
/ more ACCURATE that sequencing (99% accuracy)
/ much FASTER than sequencing (5 days and not months)
/ cost EFFECTIVE (up to 10 times more)

B) The HeartDecode system.
HeartDecode system delivers value through its scalable solutions in data processing and clinical genetic reporting based on sophisticated know-how and computational tools.
Key benefits
/ unique and user-friendly genetic reporting platform
/ enables the efficient generation of an unlimited number of genetic reports. Reports include:
    1.Table of results
    2.Results interpretation
    3.Supporting text and bibliography
    4.Language customization
/ independent from genetic testing technology

  TARGET MARKETS / CLIENTS

A) HeartGenetics’ Genetic Testing:
Clinical segments: Cardiology, Obstetrics, Genecology and Ophthalmology.
Clients: Hospitals and clinics; Healthcare channels

B) HeartDecode system
Segments: All fields with genetic tests
Clients: Genetic testing Platforms and genetic tests companies
  Contact Name:Ana Teresa Freitas

Address:
HEARTGENETICS GENETICS AND
BIOTECHNOLOGY, S.A.
Biocant, núcleo 04 - Lote 4A, Cantanhede,
3060-197 Cantanhede, Portugal  
 

Phone: +351 231 410 896
Email: contact@heartgenetics.com
www.heartgenetics.com

Share |